M. Stanley Branch, MD

Duke Adult Comprehensive Sickle Cell Center, located in Durham, NC, is part of the Duke Health system, offering advanced medical care and innovative treatments for patients with various health conditions, including sickle cell disease and cancer. The center emphasizes patient-centered care, with a strong commitment to research and the development of new therapies aimed at improving patient outcomes. Duke Health is renowned for its multidisciplinary approach to healthcare, integrating advanced clinical practices with cutting-edge research initiatives. Their focus on conditions such as Alzheimer's disease, lung cancer, and throat cancer showcases their dedication to addressing complex health challenges through comprehensive patient care and expert medical guidance. Generated from the website

Duke Rheumatology in Durham, NC, provides specialized care for individuals with rheumatic conditions, offering expert diagnosis and treatment options to manage symptoms and improve quality of life. Their team of experienced rheumatologists is dedicated to helping patients navigate the complexities of autoimmune diseases and musculoskeletal disorders. Patients at Duke Rheumatology benefit from personalized treatment plans tailored to their specific needs, integrating the latest medical advancements and therapies. The clinic's holistic approach emphasizes patient education and empowerment, fostering a collaborative environment where individuals actively participate in their healthcare journey. Generated from the website content

Dr. Gerard C. Blobe MD, located in Durham, NC, is a distinguished Medical Oncologist at Duke Health. Specializing in gastrointestinal diseases, with a focus on colorectal and pancreatic cancer, Dr. Blobe provides compassionate care to his patients. Believing in a holistic approach to cancer care, he collaborates with colleagues in surgical and radiation oncology at Duke Cancer Center. With a dedication to research, Dr. Blobe's lab focuses on signaling pathways in human cancers, particularly TGF-ß superfamily signaling pathways and pancreatic cancer. By identifying novel regulators in these pathways, his research aims to enhance diagnostic markers and therapeutic targets in human cancers. Patients benefit from access to cutting-edge clinical trials due to the innovative research conducted by Dr. Blobe and his team. Recognized for his excellence in care provision, Dr. Blobe has received an impressive overall provider rating of 4.93 out of 5 based on 122 ratings and 5 reviews. Patients appreciate his personalized approach and commitment to understanding each individual not just as a patient but as a member of their families and community. Generated from the website content